By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy
- Home
- Medical Devices
- Report Detail
Highlights
The global Human Organoids market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Human Organoids is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Human Organoids is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Human Organoids include BioIVT (US), Thermo Fisher Scientific (US), ZenBio (US), Corning (US), Organovo (US), Cyprio (France), Biopredic International (France), CELLINK (Sweden) and Emulate (US), etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Organoids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Organoids.
The Human Organoids market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Human Organoids market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Organoids manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
- BioIVT (US)
- Thermo Fisher Scientific (US)
- ZenBio (US)
- Corning (US)
- Organovo (US)
- Cyprio (France)
- Biopredic International (France)
- CELLINK (Sweden)
- Emulate (US)
- Hrel Corporation (US)
- InSphero (Switzerland)
- Kerafast (US)
- Kirkstall (UK)
- MIMETAS (Netherlands)
- Pandorum Technologies (India)
- Promethera Biosciences (Belgium)
- Miromatrix (US)
- System1 Biosciences (US)
- Cyfuse Biomedical (Japan)
Segment by Type
- Ready To Use Products
- Customizable Products
Segment by Application
- Developmental Biology
- Drug Toxicity & Efficacy Testing
- Disease Pathology
- Personalized Medicine
- Regenerative Medicine
- Other
Consumption by Region
- North America
- - United States
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - China Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Organoids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Organoids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Table of Contents
1 Human Organoids Market Overview
1.1 Product Overview and Scope of Human Organoids
1.2 Human Organoids Segment by Type
1.2.1 Global Human Organoids Market Value Comparison by Type (2023-2029)
1.2.2 Ready To Use Products
1.2.3 Customizable Products
1.3 Human Organoids Segment by Application
1.3.1 Global Human Organoids Market Value by Application: (2023-2029)
1.3.2 Developmental Biology
1.3.3 Drug Toxicity & Efficacy Testing
1.3.4 Disease Pathology
1.3.5 Personalized Medicine
1.3.6 Regenerative Medicine
1.3.7 Other
1.4 Global Human Organoids Market Size Estimates and Forecasts
1.4.1 Global Human Organoids Revenue 2018-2029
1.4.2 Global Human Organoids Sales 2018-2029
1.4.3 Global Human Organoids Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Human Organoids Market Competition by Manufacturers
2.1 Global Human Organoids Sales Market Share by Manufacturers (2018-2023)
2.2 Global Human Organoids Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Human Organoids Average Price by Manufacturers (2018-2023)
2.4 Global Human Organoids Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Human Organoids, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Organoids, Product Type & Application
2.7 Human Organoids Market Competitive Situation and Trends
2.7.1 Human Organoids Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Organoids Players Market Share by Revenue
2.7.3 Global Human Organoids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Organoids Retrospective Market Scenario by Region
3.1 Global Human Organoids Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Human Organoids Global Human Organoids Sales by Region: 2018-2029
3.2.1 Global Human Organoids Sales by Region: 2018-2023
3.2.2 Global Human Organoids Sales by Region: 2024-2029
3.3 Global Human Organoids Global Human Organoids Revenue by Region: 2018-2029
3.3.1 Global Human Organoids Revenue by Region: 2018-2023
3.3.2 Global Human Organoids Revenue by Region: 2024-2029
3.4 North America Human Organoids Market Facts & Figures by Country
3.4.1 North America Human Organoids Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Human Organoids Sales by Country (2018-2029)
3.4.3 North America Human Organoids Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Organoids Market Facts & Figures by Country
3.5.1 Europe Human Organoids Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Human Organoids Sales by Country (2018-2029)
3.5.3 Europe Human Organoids Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Organoids Market Facts & Figures by Country
3.6.1 Asia Pacific Human Organoids Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Human Organoids Sales by Country (2018-2029)
3.6.3 Asia Pacific Human Organoids Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Organoids Market Facts & Figures by Country
3.7.1 Latin America Human Organoids Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Human Organoids Sales by Country (2018-2029)
3.7.3 Latin America Human Organoids Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Organoids Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Organoids Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Human Organoids Sales by Country (2018-2029)
3.8.3 Middle East and Africa Human Organoids Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Organoids Sales by Type (2018-2029)
4.1.1 Global Human Organoids Sales by Type (2018-2023)
4.1.2 Global Human Organoids Sales by Type (2024-2029)
4.1.3 Global Human Organoids Sales Market Share by Type (2018-2029)
4.2 Global Human Organoids Revenue by Type (2018-2029)
4.2.1 Global Human Organoids Revenue by Type (2018-2023)
4.2.2 Global Human Organoids Revenue by Type (2024-2029)
4.2.3 Global Human Organoids Revenue Market Share by Type (2018-2029)
4.3 Global Human Organoids Price by Type (2018-2029)
5 Segment by Application
5.1 Global Human Organoids Sales by Application (2018-2029)
5.1.1 Global Human Organoids Sales by Application (2018-2023)
5.1.2 Global Human Organoids Sales by Application (2024-2029)
5.1.3 Global Human Organoids Sales Market Share by Application (2018-2029)
5.2 Global Human Organoids Revenue by Application (2018-2029)
5.2.1 Global Human Organoids Revenue by Application (2018-2023)
5.2.2 Global Human Organoids Revenue by Application (2024-2029)
5.2.3 Global Human Organoids Revenue Market Share by Application (2018-2029)
5.3 Global Human Organoids Price by Application (2018-2029)
6 Key Companies Profiled
6.1 BioIVT (US)
6.1.1 BioIVT (US) Corporation Information
6.1.2 BioIVT (US) Description and Business Overview
6.1.3 BioIVT (US) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.1.4 BioIVT (US) Human Organoids Product Portfolio
6.1.5 BioIVT (US) Recent Developments/Updates
6.2 Thermo Fisher Scientific (US)
6.2.1 Thermo Fisher Scientific (US) Corporation Information
6.2.2 Thermo Fisher Scientific (US) Description and Business Overview
6.2.3 Thermo Fisher Scientific (US) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Thermo Fisher Scientific (US) Human Organoids Product Portfolio
6.2.5 Thermo Fisher Scientific (US) Recent Developments/Updates
6.3 ZenBio (US)
6.3.1 ZenBio (US) Corporation Information
6.3.2 ZenBio (US) Description and Business Overview
6.3.3 ZenBio (US) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.3.4 ZenBio (US) Human Organoids Product Portfolio
6.3.5 ZenBio (US) Recent Developments/Updates
6.4 Corning (US)
6.4.1 Corning (US) Corporation Information
6.4.2 Corning (US) Description and Business Overview
6.4.3 Corning (US) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Corning (US) Human Organoids Product Portfolio
6.4.5 Corning (US) Recent Developments/Updates
6.5 Organovo (US)
6.5.1 Organovo (US) Corporation Information
6.5.2 Organovo (US) Description and Business Overview
6.5.3 Organovo (US) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Organovo (US) Human Organoids Product Portfolio
6.5.5 Organovo (US) Recent Developments/Updates
6.6 Cyprio (France)
6.6.1 Cyprio (France) Corporation Information
6.6.2 Cyprio (France) Description and Business Overview
6.6.3 Cyprio (France) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Cyprio (France) Human Organoids Product Portfolio
6.6.5 Cyprio (France) Recent Developments/Updates
6.7 Biopredic International (France)
6.6.1 Biopredic International (France) Corporation Information
6.6.2 Biopredic International (France) Description and Business Overview
6.6.3 Biopredic International (France) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biopredic International (France) Human Organoids Product Portfolio
6.7.5 Biopredic International (France) Recent Developments/Updates
6.8 CELLINK (Sweden)
6.8.1 CELLINK (Sweden) Corporation Information
6.8.2 CELLINK (Sweden) Description and Business Overview
6.8.3 CELLINK (Sweden) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.8.4 CELLINK (Sweden) Human Organoids Product Portfolio
6.8.5 CELLINK (Sweden) Recent Developments/Updates
6.9 Emulate (US)
6.9.1 Emulate (US) Corporation Information
6.9.2 Emulate (US) Description and Business Overview
6.9.3 Emulate (US) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Emulate (US) Human Organoids Product Portfolio
6.9.5 Emulate (US) Recent Developments/Updates
6.10 Hrel Corporation (US)
6.10.1 Hrel Corporation (US) Corporation Information
6.10.2 Hrel Corporation (US) Description and Business Overview
6.10.3 Hrel Corporation (US) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Hrel Corporation (US) Human Organoids Product Portfolio
6.10.5 Hrel Corporation (US) Recent Developments/Updates
6.11 InSphero (Switzerland)
6.11.1 InSphero (Switzerland) Corporation Information
6.11.2 InSphero (Switzerland) Human Organoids Description and Business Overview
6.11.3 InSphero (Switzerland) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.11.4 InSphero (Switzerland) Human Organoids Product Portfolio
6.11.5 InSphero (Switzerland) Recent Developments/Updates
6.12 Kerafast (US)
6.12.1 Kerafast (US) Corporation Information
6.12.2 Kerafast (US) Human Organoids Description and Business Overview
6.12.3 Kerafast (US) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Kerafast (US) Human Organoids Product Portfolio
6.12.5 Kerafast (US) Recent Developments/Updates
6.13 Kirkstall (UK)
6.13.1 Kirkstall (UK) Corporation Information
6.13.2 Kirkstall (UK) Human Organoids Description and Business Overview
6.13.3 Kirkstall (UK) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Kirkstall (UK) Human Organoids Product Portfolio
6.13.5 Kirkstall (UK) Recent Developments/Updates
6.14 MIMETAS (Netherlands)
6.14.1 MIMETAS (Netherlands) Corporation Information
6.14.2 MIMETAS (Netherlands) Human Organoids Description and Business Overview
6.14.3 MIMETAS (Netherlands) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.14.4 MIMETAS (Netherlands) Human Organoids Product Portfolio
6.14.5 MIMETAS (Netherlands) Recent Developments/Updates
6.15 Pandorum Technologies (India)
6.15.1 Pandorum Technologies (India) Corporation Information
6.15.2 Pandorum Technologies (India) Human Organoids Description and Business Overview
6.15.3 Pandorum Technologies (India) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Pandorum Technologies (India) Human Organoids Product Portfolio
6.15.5 Pandorum Technologies (India) Recent Developments/Updates
6.16 Promethera Biosciences (Belgium)
6.16.1 Promethera Biosciences (Belgium) Corporation Information
6.16.2 Promethera Biosciences (Belgium) Human Organoids Description and Business Overview
6.16.3 Promethera Biosciences (Belgium) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Promethera Biosciences (Belgium) Human Organoids Product Portfolio
6.16.5 Promethera Biosciences (Belgium) Recent Developments/Updates
6.17 Miromatrix (US)
6.17.1 Miromatrix (US) Corporation Information
6.17.2 Miromatrix (US) Human Organoids Description and Business Overview
6.17.3 Miromatrix (US) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Miromatrix (US) Human Organoids Product Portfolio
6.17.5 Miromatrix (US) Recent Developments/Updates
6.18 System1 Biosciences (US)
6.18.1 System1 Biosciences (US) Corporation Information
6.18.2 System1 Biosciences (US) Human Organoids Description and Business Overview
6.18.3 System1 Biosciences (US) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.18.4 System1 Biosciences (US) Human Organoids Product Portfolio
6.18.5 System1 Biosciences (US) Recent Developments/Updates
6.19 Cyfuse Biomedical (Japan)
6.19.1 Cyfuse Biomedical (Japan) Corporation Information
6.19.2 Cyfuse Biomedical (Japan) Human Organoids Description and Business Overview
6.19.3 Cyfuse Biomedical (Japan) Human Organoids Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Cyfuse Biomedical (Japan) Human Organoids Product Portfolio
6.19.5 Cyfuse Biomedical (Japan) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Organoids Industry Chain Analysis
7.2 Human Organoids Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Organoids Production Mode & Process
7.4 Human Organoids Sales and Marketing
7.4.1 Human Organoids Sales Channels
7.4.2 Human Organoids Distributors
7.5 Human Organoids Customers
8 Human Organoids Market Dynamics
8.1 Human Organoids Industry Trends
8.2 Human Organoids Market Drivers
8.3 Human Organoids Market Challenges
8.4 Human Organoids Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Human Organoids Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Human Organoids Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Human Organoids Market Competitive Situation by Manufacturers in 2022
Table 4. Global Human Organoids Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Human Organoids Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Human Organoids Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Human Organoids Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Human Organoids Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Human Organoids, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Human Organoids, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Organoids, Product Type & Application
Table 12. Global Key Manufacturers of Human Organoids, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Organoids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Organoids as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Organoids Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Human Organoids Sales by Region (2018-2023) & (K Units)
Table 18. Global Human Organoids Sales Market Share by Region (2018-2023)
Table 19. Global Human Organoids Sales by Region (2024-2029) & (K Units)
Table 20. Global Human Organoids Sales Market Share by Region (2024-2029)
Table 21. Global Human Organoids Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Human Organoids Revenue Market Share by Region (2018-2023)
Table 23. Global Human Organoids Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Human Organoids Revenue Market Share by Region (2024-2029)
Table 25. North America Human Organoids Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Human Organoids Sales by Country (2018-2023) & (K Units)
Table 27. North America Human Organoids Sales by Country (2024-2029) & (K Units)
Table 28. North America Human Organoids Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Human Organoids Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Human Organoids Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Human Organoids Sales by Country (2018-2023) & (K Units)
Table 32. Europe Human Organoids Sales by Country (2024-2029) & (K Units)
Table 33. Europe Human Organoids Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Human Organoids Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Human Organoids Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Human Organoids Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Human Organoids Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Human Organoids Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Human Organoids Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Human Organoids Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Human Organoids Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Human Organoids Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Human Organoids Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Human Organoids Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Human Organoids Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Human Organoids Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Human Organoids Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Human Organoids Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Human Organoids Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Human Organoids Sales (K Units) by Type (2018-2023)
Table 51. Global Human Organoids Sales (K Units) by Type (2024-2029)
Table 52. Global Human Organoids Sales Market Share by Type (2018-2023)
Table 53. Global Human Organoids Sales Market Share by Type (2024-2029)
Table 54. Global Human Organoids Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Human Organoids Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Human Organoids Revenue Market Share by Type (2018-2023)
Table 57. Global Human Organoids Revenue Market Share by Type (2024-2029)
Table 58. Global Human Organoids Price (US$/Unit) by Type (2018-2023)
Table 59. Global Human Organoids Price (US$/Unit) by Type (2024-2029)
Table 60. Global Human Organoids Sales (K Units) by Application (2018-2023)
Table 61. Global Human Organoids Sales (K Units) by Application (2024-2029)
Table 62. Global Human Organoids Sales Market Share by Application (2018-2023)
Table 63. Global Human Organoids Sales Market Share by Application (2024-2029)
Table 64. Global Human Organoids Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Human Organoids Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Human Organoids Revenue Market Share by Application (2018-2023)
Table 67. Global Human Organoids Revenue Market Share by Application (2024-2029)
Table 68. Global Human Organoids Price (US$/Unit) by Application (2018-2023)
Table 69. Global Human Organoids Price (US$/Unit) by Application (2024-2029)
Table 70. BioIVT (US) Corporation Information
Table 71. BioIVT (US) Description and Business Overview
Table 72. BioIVT (US) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. BioIVT (US) Human Organoids Product
Table 74. BioIVT (US) Recent Developments/Updates
Table 75. Thermo Fisher Scientific (US) Corporation Information
Table 76. Thermo Fisher Scientific (US) Description and Business Overview
Table 77. Thermo Fisher Scientific (US) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Thermo Fisher Scientific (US) Human Organoids Product
Table 79. Thermo Fisher Scientific (US) Recent Developments/Updates
Table 80. ZenBio (US) Corporation Information
Table 81. ZenBio (US) Description and Business Overview
Table 82. ZenBio (US) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. ZenBio (US) Human Organoids Product
Table 84. ZenBio (US) Recent Developments/Updates
Table 85. Corning (US) Corporation Information
Table 86. Corning (US) Description and Business Overview
Table 87. Corning (US) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Corning (US) Human Organoids Product
Table 89. Corning (US) Recent Developments/Updates
Table 90. Organovo (US) Corporation Information
Table 91. Organovo (US) Description and Business Overview
Table 92. Organovo (US) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Organovo (US) Human Organoids Product
Table 94. Organovo (US) Recent Developments/Updates
Table 95. Cyprio (France) Corporation Information
Table 96. Cyprio (France) Description and Business Overview
Table 97. Cyprio (France) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Cyprio (France) Human Organoids Product
Table 99. Cyprio (France) Recent Developments/Updates
Table 100. Biopredic International (France) Corporation Information
Table 101. Biopredic International (France) Description and Business Overview
Table 102. Biopredic International (France) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Biopredic International (France) Human Organoids Product
Table 104. Biopredic International (France) Recent Developments/Updates
Table 105. CELLINK (Sweden) Corporation Information
Table 106. CELLINK (Sweden) Description and Business Overview
Table 107. CELLINK (Sweden) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. CELLINK (Sweden) Human Organoids Product
Table 109. CELLINK (Sweden) Recent Developments/Updates
Table 110. Emulate (US) Corporation Information
Table 111. Emulate (US) Description and Business Overview
Table 112. Emulate (US) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Emulate (US) Human Organoids Product
Table 114. Emulate (US) Recent Developments/Updates
Table 115. Hrel Corporation (US) Corporation Information
Table 116. Hrel Corporation (US) Description and Business Overview
Table 117. Hrel Corporation (US) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Hrel Corporation (US) Human Organoids Product
Table 119. Hrel Corporation (US) Recent Developments/Updates
Table 120. InSphero (Switzerland) Corporation Information
Table 121. InSphero (Switzerland) Description and Business Overview
Table 122. InSphero (Switzerland) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. InSphero (Switzerland) Human Organoids Product
Table 124. InSphero (Switzerland) Recent Developments/Updates
Table 125. Kerafast (US) Corporation Information
Table 126. Kerafast (US) Description and Business Overview
Table 127. Kerafast (US) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Kerafast (US) Human Organoids Product
Table 129. Kerafast (US) Recent Developments/Updates
Table 130. Kirkstall (UK) Corporation Information
Table 131. Kirkstall (UK) Description and Business Overview
Table 132. Kirkstall (UK) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Kirkstall (UK) Human Organoids Product
Table 134. Kirkstall (UK) Recent Developments/Updates
Table 135. MIMETAS (Netherlands) Corporation Information
Table 136. MIMETAS (Netherlands) Description and Business Overview
Table 137. MIMETAS (Netherlands) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. MIMETAS (Netherlands) Human Organoids Product
Table 139. MIMETAS (Netherlands) Recent Developments/Updates
Table 140. Pandorum Technologies (India) Corporation Information
Table 141. Pandorum Technologies (India) Description and Business Overview
Table 142. Pandorum Technologies (India) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Pandorum Technologies (India) Human Organoids Product
Table 144. Pandorum Technologies (India) Recent Developments/Updates
Table 145. Promethera Biosciences (Belgium) Corporation Information
Table 146. Promethera Biosciences (Belgium) Description and Business Overview
Table 147. Promethera Biosciences (Belgium) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Promethera Biosciences (Belgium) Human Organoids Product
Table 149. Promethera Biosciences (Belgium) Recent Developments/Updates
Table 150. Miromatrix (US) Corporation Information
Table 151. Miromatrix (US) Description and Business Overview
Table 152. Miromatrix (US) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Miromatrix (US) Human Organoids Product
Table 154. Miromatrix (US) Recent Developments/Updates
Table 155. System1 Biosciences (US) Corporation Information
Table 156. System1 Biosciences (US) Description and Business Overview
Table 157. System1 Biosciences (US) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. System1 Biosciences (US) Human Organoids Product
Table 159. System1 Biosciences (US) Recent Developments/Updates
Table 160. Cyfuse Biomedical (Japan) Corporation Information
Table 161. Cyfuse Biomedical (Japan) Description and Business Overview
Table 162. Cyfuse Biomedical (Japan) Human Organoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Cyfuse Biomedical (Japan) Human Organoids Product
Table 164. Cyfuse Biomedical (Japan) Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Human Organoids Distributors List
Table 168. Human Organoids Customers List
Table 169. Human Organoids Market Trends
Table 170. Human Organoids Market Drivers
Table 171. Human Organoids Market Challenges
Table 172. Human Organoids Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Organoids
Figure 2. Global Human Organoids Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Human Organoids Market Share by Type in 2022 & 2029
Figure 4. Ready To Use Products Product Picture
Figure 5. Customizable Products Product Picture
Figure 6. Global Human Organoids Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Human Organoids Market Share by Application in 2022 & 2029
Figure 8. Developmental Biology
Figure 9. Drug Toxicity & Efficacy Testing
Figure 10. Disease Pathology
Figure 11. Personalized Medicine
Figure 12. Regenerative Medicine
Figure 13. Other
Figure 14. Global Human Organoids Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Human Organoids Market Size (2018-2029) & (US$ Million)
Figure 16. Global Human Organoids Sales (2018-2029) & (K Units)
Figure 17. Global Human Organoids Average Price (US$/Unit) & (2018-2029)
Figure 18. Human Organoids Report Years Considered
Figure 19. Human Organoids Sales Share by Manufacturers in 2022
Figure 20. Global Human Organoids Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Human Organoids Players: Market Share by Revenue in 2022
Figure 22. Human Organoids Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Human Organoids Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Human Organoids Sales Market Share by Country (2018-2029)
Figure 25. North America Human Organoids Revenue Market Share by Country (2018-2029)
Figure 26. United States Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Human Organoids Sales Market Share by Country (2018-2029)
Figure 29. Europe Human Organoids Revenue Market Share by Country (2018-2029)
Figure 30. Germany Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Human Organoids Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Human Organoids Revenue Market Share by Region (2018-2029)
Figure 37. China Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Human Organoids Sales Market Share by Country (2018-2029)
Figure 47. Latin America Human Organoids Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Human Organoids Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Human Organoids Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Human Organoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Human Organoids Revenue Growth Rate (2018-2029) & (US
Write comment about above report:
Related Reports
|
Global Human Organoids Market Insights and Forecast to 2028
Human Organoids market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Human Organoids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analys... |
|
Global Human Organoids Market Research Report 2022
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segme... |
|
Global Human Organoids Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % du... |
|
Global Human Organoids Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Human Organoids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market player... |
|
Global Human Organoids Market Research Report 2021
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme... |
|
Global Human Organoids Market Growth 2021-2026
According to this latest study, the 2020 growth of Human Organoids will have significant change from previous year. By the most conservative estimates of global Human Organoids market size (most likely outcome) will be a year-over-year revenue growth... |
|
Global and China Human Organoids Market Insights, Forecast to 2027
Human Organoids market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Human Organoids market will be able to gain the upper hand as they use the report as a powerful... |
|
Human Organoids Market by Product (Pancreas, Kidney, Lung, GIT, Liver Models) Usabilty (Customized, Ready-To-Use), Application (Toxicity, Pathology, Personalized & Regenerative Medicine), Enduser (Pharma-Biotech, CROs, Academia) - Global Forecast to 2025
“The global human organoids market is projected to grow at a CAGR of 17.5% during the forecast period” The global human organoids market size is projected to reach USD 1,901 million by 2025 from USD 850 million... |
|
Human Liver Models Market by Drug Discovery Platform (Non-alcoholic Fatty Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - Global Forecast to 2022
“The human liver models market is projected to grow at a CAGR of 13.6% during the forecast period” The global human liver models market is expected to reach USD 2.56 billion by 2022 from USD 1.35 billion in 201... |
We are on:
Why ReportsnReports.com?
- 500,000 market research reports and growing.
- Top Fortune 500 Organizations trust us for research data.
- 24/7 support on call as well as emails.
- Your Details are safe with us.
- Free support for your research requirements.
- Report Delivery: Email
- Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays